158 related articles for article (PubMed ID: 7226018)
1. Staging lymphography with respect to lymph node histology, treatment, and follow-up in patients with mycosis fungoides.
Hamminga L; Mulder JD; Evans C; Scheffer E; Meyer CJ; Van Vloten WA
Cancer; 1981 Feb; 47(4):692-7. PubMed ID: 7226018
[TBL] [Abstract][Full Text] [Related]
2. Lymphography in the assessment of mycosis fungoides.
Tallroth K; Wiljasalo M; Valle M; Korhola O
Lymphology; 1977 Sep; 10(3):147-50. PubMed ID: 592885
[TBL] [Abstract][Full Text] [Related]
3. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
4. Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides.
Scheffer E; Meijer CJ; Van Vloten WA
Cancer; 1980 Jan; 45(1):137-48. PubMed ID: 7350998
[TBL] [Abstract][Full Text] [Related]
5. Staging procedures in mycosis fungoides.
Griem ML; Moran EM; Ferguson DJ; Mettler FA; Griem SF
Br J Cancer Suppl; 1975 Mar; 2():362-7. PubMed ID: 1182074
[TBL] [Abstract][Full Text] [Related]
6. Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications.
Kern DE; Kidd PG; Moe R; Hanke D; Olerud JE
Arch Dermatol; 1998 Feb; 134(2):158-64. PubMed ID: 9487207
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides.
de Coninck EC; Kim YH; Varghese A; Hoppe RT
J Clin Oncol; 2001 Feb; 19(3):779-84. PubMed ID: 11157031
[TBL] [Abstract][Full Text] [Related]
8. Lymph node grading for staging of mycosis fungoides may benefit from examination of multiple excised lymph nodes.
Breneman DL; Raju US; Breneman JC; Steele PE; McFadden DW; Cualing HD; Nussbaum MS; Swerdlow SH
J Am Acad Dermatol; 2003 May; 48(5):702-6. PubMed ID: 12734498
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of membrane markers and morphometric characteristics of lymphoid cells in blood and lymph nodes from patients with mycosis fungoides.
van der Loo EM; Meijer CJ; Scheffer E; van Vloten WA
Cancer; 1981 Aug; 48(3):738-44. PubMed ID: 6454478
[TBL] [Abstract][Full Text] [Related]
10. Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.
Lamberg SI; Green SB; Byar DP; Block JB; Clendenning WE; Epstein EH; Fuks ZY; Golitz LE; Lorincz AL; Michel B; Roenigk HH; Van Scott EJ; Vonderheid EC; Thomas RJ
Cancer Treat Rep; 1979 Apr; 63(4):701-7. PubMed ID: 376140
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
Sausville EA; Eddy JL; Makuch RW; Fischmann AB; Schechter GP; Matthews M; Glatstein E; Ihde DC; Kaye F; Veach SR
Ann Intern Med; 1988 Sep; 109(5):372-82. PubMed ID: 3408055
[TBL] [Abstract][Full Text] [Related]
12. Experience with lymphography in patients with mycosis fungoides.
Castellino RA; Hoppe RT; Blank N; Young SW; Fuks Z
Cancer Treat Rep; 1979 Apr; 63(4):581-6. PubMed ID: 445513
[No Abstract] [Full Text] [Related]
13. Intramammary lymph node involvement by mycosis fungoides diagnosed by fine-needle aspiration biopsy.
Laforga JB; Chordá D; Sevilla F
Diagn Cytopathol; 1998 Aug; 19(2):124-6. PubMed ID: 9702491
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
[TBL] [Abstract][Full Text] [Related]
15. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients.
van Doorn R; Van Haselen CW; van Voorst Vader PC; Geerts ML; Heule F; de Rie M; Steijlen PM; Dekker SK; van Vloten WA; Willemze R
Arch Dermatol; 2000 Apr; 136(4):504-10. PubMed ID: 10768649
[TBL] [Abstract][Full Text] [Related]
16. Mycosis fungoides.
Sterry W
Curr Top Pathol; 1985; 74():167-223. PubMed ID: 3882347
[No Abstract] [Full Text] [Related]
17. [Lymph node histopathologic aspects in cutaneous lymphomas of the mycosis fungoides or Sézary syndrome type. Retrospective study of 98 biopsies].
Wechsler J; Diebold J; Gerard-Marchant R
Ann Pathol; 1987; 7(2):122-9. PubMed ID: 3620027
[TBL] [Abstract][Full Text] [Related]
18. Lymph node biopsy in mycosis fungoides.
Colby TV; Burke JS; Hoppe RT
Cancer; 1981 Jan; 47(2):351-9. PubMed ID: 7459823
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
20. Results of lymphography in early mycosis fungoides.
Zachariae H; Bjerring P; Grunnet E; Thestrup-Petersen K; Davidsen D
Acta Derm Venereol; 1983; 63(3):255-7. PubMed ID: 6192648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
